EPA:ALSGD - Euronext Paris - Matif - FR0011464452 - Common Stock - Currency: EUR
EPA:ALSGD (3/7/2025, 7:00:00 PM)
0.193
+0 (+0.63%)
The current stock price of ALSGD.PA is 0.193 EUR. In the past month the price decreased by -4.93%. In the past year, price decreased by -29.04%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 29.15 | 217.38B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 69.31 | 166.86B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 39.18 | 133.56B | ||
1BSX.MI | BOSTON SCIENTIFIC CORP | 39.52 | 133.38B | ||
1MDT.MI | MEDTRONIC PLC | 17.48 | 113.17B | ||
2M6.DE | MEDTRONIC PLC | 17.56 | 110.81B | ||
1SHL.MI | SIEMENS HEALTHINEERS AG | 25.27 | 60.49B | ||
BOX.DE | BECTON DICKINSON AND CO | 16.4 | 60.33B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 23.49 | 59.08B | ||
1EW.MI | EDWARDS LIFESCIENCES CORP | 26.07 | 39.21B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 26.65 | 37.76B | ||
DC4.DE | DEXCOM INC | 48.5 | 28.81B |
Spineguard SA engages in the design and manufacture of medical devices for the spine. The company is headquartered in Vincennes, Ile-De-France and currently employs 24 full-time employees. The company went IPO on 2013-04-29. The firm involves with the DSG (Dynamic Surgical Guidance) technology that concentrates on the placement of bone implants for the benefit of patients, surgeons, hospital staff, and healthcare systems. The DSG digital technology platform is a real-time surgical guidance work based on the measurement of local electrical conductivity of tissues without X-rays that includes PediGuard devices, the manual instruments capable of alerting surgeons in real time to potential pedicle or vertebral breaches. The technology is also implemented for the surgical robots to improve the safety, accuracy and autonomy.
SPINEGUARD SA
10, Cours Louis Lumiere
Vincennes ILE-DE-FRANCE FR
Employees: 24
Company Website: https://www.spineguard.com/fr/
Investor Relations: http://www.spineguard.fr/investisseurs/
Phone: 33145184519
The current stock price of ALSGD.PA is 0.193 EUR. The price increased by 0.63% in the last trading session.
The exchange symbol of SPINEGUARD SA is ALSGD and it is listed on the Euronext Paris - Matif exchange.
ALSGD.PA stock is listed on the Euronext Paris - Matif exchange.
9 analysts have analysed ALSGD.PA and the average price target is 0.77 EUR. This implies a price increase of 296.37% is expected in the next year compared to the current price of 0.193. Check the SPINEGUARD SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SPINEGUARD SA (ALSGD.PA) has a market capitalization of 10.79M EUR. This makes ALSGD.PA a Nano Cap stock.
SPINEGUARD SA (ALSGD.PA) currently has 24 employees.
SPINEGUARD SA (ALSGD.PA) has a resistance level at 0.2. Check the full technical report for a detailed analysis of ALSGD.PA support and resistance levels.
The Revenue of SPINEGUARD SA (ALSGD.PA) is expected to grow by 3.81% in the next year. Check the estimates tab for more information on the ALSGD.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALSGD.PA does not pay a dividend.
SPINEGUARD SA (ALSGD.PA) will report earnings on 2025-04-15, after the market close.
SPINEGUARD SA (ALSGD.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.09).
ChartMill assigns a fundamental rating of 2 / 10 to ALSGD.PA. Both the profitability and financial health of ALSGD.PA have multiple concerns.
Over the last trailing twelve months ALSGD.PA reported a non-GAAP Earnings per Share(EPS) of -0.09. The EPS increased by 2.44% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -41.75% | ||
ROE | -86.49% | ||
Debt/Equity | 0.57 |
ChartMill assigns a Buy % Consensus number of 84% to ALSGD.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -44.99% and a revenue growth 3.81% for ALSGD.PA